.Your missionThe Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conducting research and driving innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases.It was created in 2010, and since then has experienced exponential growth.
The IJC is part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024.Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC).
Additionally, IJC is integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as an Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services.The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Trueta, Hospital del Mar, and Hospital San Joan de Déu.
This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.RESEARCH DESCRIPTION The Cuartero lab is seeking a highly motivated RESEARCHER ASSISTANT to join our team.
We investigate the mechanisms that regulate transcription in normal blood development and leukemia.Acute myeloid leukemia (AML) is one of the most aggressive forms of leukemia, and there is an urgent need for new treatment options.
Although the genes recurrently mutated in AML are known, the reasons these mutations drive malignancy remain unclear.
Our research aims to address the following questions:What transcriptional mechanisms are deregulated in acute myeloid leukemia?How do inflammatory signals influence leukemic progression?Can inflammatory modulation attenuate the severity of myeloid malignancies?Our previous work has demonstrated that alterations in enhancer-promoter contacts and three-dimensional genome organization are critical drivers of leukemia.
We are now focused on identifying additional proteins involved in these processes.We encourage applications from highly motivated scientists with a strong interest in epigenetics, hematopoiesis, or leukemia.
This contract is part of the RYC2021-033018-I grant funded by MICIU/AEI/10.13039/501100011033 and by the European Union NextGeneration EU/PRTR.Your profile WHAT WE NEEDWe are seeking a highly motivated, talented researcher assistant to join our team and contribute to this exciting project